Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
349.5 USD +0.32% Intraday chart for Humana Inc. +0.38% -23.66%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Raymond James Starts Humana With Market Perform Rating MT
Humana Partners With DUOS on Health Care for Louisiana Veterans MT
Health services provider Concentra confidentially files for US IPO RE
Humana Completes $2.25 Billion Debt Offering MT
Argus Downgrades Humana to Hold From Buy MT
Humana Prices Offering of $2.25 Billion Worth of Notes MT
Humana Inc Urges Shareholders to Vote Against a Shareholder Proposal Submitted by John Chevedden CI
Humana Files Mixed Shelf MT
UnitedHealth hack clouds outlook for insurers' medical costs RE
Humana Expands Partnership With Strive Health to Increase Kidney Care Access MT
Transcript : Humana Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 09:10 AM
Humana Announces Strategic Partnership with Veda to Improve Accuracy of Provider Directories CI
John Chevedden Submits a Shareholder Proposal to Humana CI
Humana Keeps Quarterly Dividend at $0.885 a Share, Payable April 26 to Holders of Record as of March 29 MT
Humana Inc. Declares Cash Dividend, Payable on April 26, 2024 CI
US hospitals see post pandemic catch-up behind insurer healthcare costs RE
Molina Healthcare beats Q4 profit estimates on higher premiums RE
CVS cuts 2024 profit forecast on elevated medical costs RE
That's good enough for investors Our Logo
ANALYST RECOMMENDATIONS : Chevron, McDonald's, Palantir, Sainsbury, Tesla... Our Logo
Cigna raises 2024 profit view, beats Q4 earnings estimates on lower costs RE
Wells Fargo Adjusts Price Target on Humana to $413 From $465, Keeps Overweight Rating MT
HCA Healthcare forecasts 2024 profit above Street estimates RE
Goldman Sachs Cuts Price Target on Humana to $450 From $515, Keeps Buy Rating MT
Nephron Research Cuts Humana Price Target to $400 From $648, Maintains Buy Rating MT
Chart Humana Inc.
More charts
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
349.5 USD
Average target price
419.6 USD
Spread / Average Target
+20.07%
Consensus
  1. Stock
  2. Equities
  3. Stock Humana Inc. - Nyse
  4. News Humana Inc.
  5. Earnings Flash (HUM) HUMANA Reports Q1 EPS $8.04, vs. Street Est of $6.79